KALOCYTE INC

KaloCyte | ErythroMer - a red blood cell substitute

Baltimore, United States · Founded 2017 · $7.7M raised

Employees
11–50
Founded
2017
Business Model
B2G
Total Funding
$7.7M
Last Round
$1.8M GrantAug 2025
Rounds
6

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

KaloCyte is a preclinical biotech developing ErythroMer™, a dried, bio-inspired artificial red blood cell designed to treat life-threatening blood loss when stored red blood cells are unavailable, undesirable, or in short supply. ErythroMer is a first-in-class nano-encapsulated human hemoglobin that mimics the complex physiology of natural red blood cells in vivo and can be freeze-dried for long-term storage at ambient conditions. Founded by researchers in red blood cell physiology, trauma care, and nanotechnology, KaloCyte has secured over $19M in DARPA, NIH, and DoD grants.

Summary

KALOCYTE INC is a Biotech company based in Baltimore, United States, founded in 2017. It has raised $7.7M in total across 6 rounds, most recently a $1.8M Grant round in Aug 2025.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantSBIR Phase II (DARPA)Aug 2025
$1.8M

Sign up to see all 6 events

Funding: Grant. Amounts, valuations, and investors where available.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

KALOCYTE INC on Indexed.vc
<a href="https://indexed.vc/companies/kalocyte-inc"><img src="https://indexed.vc/api/badge/company/kalocyte-inc" alt="KALOCYTE INC on Indexed.vc" width="260" height="76" /></a>